Niti Aayog and Oracle Venture on Blockchain Technology

2019 ias preliminary exam test series

In order to fight the growing problem of counterfeit drugs in India, NITI Aayog and Oracle signed a Statement of Intent (SoI) to pilot a real drug supply-chain using blockchain distributed ledger and Internet of Things (IoT) software.

Apollo Hospitals and Strides Pharma Sciences partnered in this effort.

This agreement with Oracle and partnership with Apollo Hospitals and Strides Pharma, will help ensure that Indian drug manufacturers and healthcare experts have access to a standards-based, modern technology platform – blockchain and IoT, to help eliminate fake drug distribution.

The major advantages of blockchain software will be its ability to allow the sharing of information across the drug supply chain securely with every exchange of information getting recorded, inability to tamper with any record of the drug movement and inability to delete any records so there can be no dispute, if an offender is caught.

About Blockchain technology in drug supply-chain: Blockchain technology helps to permanently register a drug’s record in the manufacturer’s drug supply chain (serial number, labelling, scanning), leaving no scope for record tampering. At every point of hand change, it records the drug’s movement – from manufacturer to logistics, to stockist to hospital, or pharmacy to consumer. In case of a fake drug, the software will detect irregularity. Additionally, critical information such as chemical ingredients of the drug or maintenance of temperature control in case of life saving drugs or vaccines, can also be tracked.

Current Affairs for IAS Exam